gastric cancer
gastric cancer
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
BIOT
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
Firefly Raises $94 Million to Revolutionize Cancer Treatment
BIOT
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍
Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
BIOT
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership
Revolutionary Kyverna Cuts CAR-T Production to 3 Days
BIOT
📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬
Astellas’ Gastric Cancer Treatment Rejected by FDA Blames CDMO
BIOT
📢 Astellas' gastric cancer antibody rejected by FDA due to CDMO issues. Setback for treatment, importance of reliable CDMO highlighted. 😞🔍🏭📉💡
